Glioblastoma is the most lethal and malignant adult brain cancer that may arise from the neuroglial stem or progenitor cells. Certain gene mutations or those with a known history of other cancers and radiation therapy may predispose patients to develop brain cancer. Tumour relapse is invaria
According to the findings of a study led by UC San Francisco, the progression of a low-grade, slow-growing brain tumour to a deadly one can be delayed if neurosurgeons remove as much as possible soon after diagnosis.
Neutropenia--low levels of white blood cells called neutrophils, which fight infection--develops in more than 80 per cent of patients who receive chemotherapy for blood cancer. It occurs because chemotherapy destroys neutrophils along with tumour cells.
The sympathetic nervous system tumour known as neuroblastoma mainly affects young children. In the Netherlands, 25 kids are given this diagnosis per year. An essential component of the therapy strategy is surgery to remove the tumour tissue. Since November 2014, the Princess Maxima Center fo
According to research published in the journal 'Nature Communications', highly active cells were found in a tumour which showed how they grow and attack normal tissues of the body.
Scientists at Duke-NUS Medical School and colleagues in Singapore have sequenced the response to viral infection in colony-bred cave nectar bats (Eonycteris spelaea) at single-cell resolution. Published in the journal Immunity, the findings contribute to insights into bat immunity that could
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement.
Cancer cells require proteins that bind copper ions in order to develop and spread throughout the human body. Recent studies on the interactions between proteins and how they bind to metals in cancer-related proteins have revealed possible new therapeutic targets.
Washington [US], September 20 (ANI): The findings of a recent study provide a novel theory as to how tumour cells avoid destruction by the immune system.